Related references
Note: Only part of the references are listed.Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
Judith Stickdorn et al.
ACS NANO (2022)
AE36 HER2/neu-derived peptide linked to positively charged liposomes with CpG-ODN as an effective therapeutic and prophylactic vaccine for breast cancer
Nastaran Barati et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)
Identification of tumor antigens with immunopeptidomics
Chloe Chong et al.
NATURE BIOTECHNOLOGY (2022)
Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma
Mona O. Mohsen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Genetic Engineering of Dendritic Cells Using Partially Zwitterionic Dendrimer-Entrapped Gold Nanoparticles Boosts Efficient Tumor Immunotherapy
Zhijun Ouyang et al.
BIOMACROMOLECULES (2022)
Methodological advances in the design of peptide-based vaccines
Parismita Kalita et al.
DRUG DISCOVERY TODAY (2022)
Improving potency of Nanoliposomal AE36 peptide vaccine by adding CD4+T cell helper epitope and MPL in TUBO breast cancer mice model
Parvin Zamani et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
Soumya Badrinath et al.
NATURE (2022)
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer
Pola Olczak et al.
JOURNAL OF VIROLOGY (2022)
Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines
Michal Hensler et al.
ONCOIMMUNOLOGY (2022)
Peptide-Drug Conjugates: A New Hope for Cancer Management
Vivek P. Chavda et al.
MOLECULES (2022)
Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer
Elie Rassy et al.
BREAST (2022)
Glycolipid-peptide conjugate vaccines elicit CD8+ T-cell responses and prevent breast cancer metastasis
Olivia K. Burn et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)
Peptides that immunoactivate the tumor microenvironment
Natsuki Furukawa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Magnetic Metal Micelles for Enhanced Delivery of Self-Immolating CD8+ T-Cell Epitopes for Cancer Immunotherapy
Jiexin Li et al.
CHEMISTRY OF MATERIALS (2021)
Vaccines targeting angiogenesis in melanoma
Fatemeh Zahedipour et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
HER2/neu-Based Peptide Vaccination-Pulsed with B-Cell Epitope Induced Efficient Prophylactic and Therapeutic Antitumor Activities in TUBO Breast Cancer Mice Model
Muhammad Luqman Nordin et al.
CANCERS (2021)
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy
DaeYong Lee et al.
ADVANCED MATERIALS (2021)
Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy
Mona Yazdani et al.
SCIENTIFIC REPORTS (2021)
Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment
Zicong He et al.
FRONTIERS IN IMMUNOLOGY (2021)
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Alexander J. Stephens et al.
FRONTIERS IN IMMUNOLOGY (2021)
Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors
Pauline Rettman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications
Jooeun Bae et al.
LEUKEMIA (2020)
A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells
Keunok Jung et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Discovery of hPRDX5-based peptide inhibitors blocking PD-1/PD-L1 interaction through in silico proteolysis and rational design
Sen Zou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
An Immune-Stimulatory Helix-Loop-Helix Peptide: Selective Inhibition of CTLA-4-B7 Interaction
Tharanga M. R. Ramanayake Mudiyanselage et al.
ACS CHEMICAL BIOLOGY (2020)
Peptide-Based Vaccines: Current Progress and Future Challenges
Ryan J. Malonis et al.
CHEMICAL REVIEWS (2020)
Delivered antigen peptides to resident CD8α+ DCs in lymph node by micelle-based vaccine augment antigen-specific CD8+ effector T cell response
Luyao Wang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
High-Throughput Identification of MHC Class I Binding Peptides Using an Ultradense Peptide Array
Amelia K. Haj et al.
JOURNAL OF IMMUNOLOGY (2020)
A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses
Wenjie Zhai et al.
ACTA PHARMACEUTICA SINICA B (2020)
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
Alexey V. Baldin et al.
CANCERS (2020)
Ex vivo pulsed dendritic cell vaccination against cancer
Yang-zhuo Gu et al.
ACTA PHARMACOLOGICA SINICA (2020)
The Role of Antigen Spreading in the Efficacy of Immunotherapies
Peter Brossart
CLINICAL CANCER RESEARCH (2020)
Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer
Parvin Zamani et al.
EUROPEAN JOURNAL OF CANCER (2020)
Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition
Lauren E. Stopfer et al.
NATURE COMMUNICATIONS (2020)
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Raju K. Vaddepally et al.
CANCERS (2020)
Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
Anna Lucia Tornesello et al.
CANCERS (2020)
Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression
Smriti Gurung et al.
BIOMATERIALS (2020)
Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer
Valeria Rolih et al.
CANCERS (2020)
Clinical efficacy and immunity of combination therapy with nivolumab and IDO/PD-L1 peptide vaccine in patients with metastatic melanoma: A phase I/II trial
I-M. Svane et al.
ANNALS OF ONCOLOGY (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma
Mona Yazdani et al.
VACCINE (2020)
Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer
Laleh Naghibi et al.
PLOS ONE (2020)
Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages
Liang Pang et al.
PHARMACEUTICAL RESEARCH (2019)
P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer
Niloofar Farzad et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo
Yang Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy
Pottayil G. Sasikumar et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Mass spectrometry based identification of MHC-bound peptides for immunopeptidomics
Anthony W. Purcell et al.
NATURE PROTOCOLS (2019)
Targeting Treg cells in cancer immunotherapy
Atsushi Tanaka et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer
Parvin Zamani et al.
JOURNAL OF CONTROLLED RELEASE (2019)
A multipeptide vaccine plus toll-like receptor agonists LPS or polylCLC in combination with incomplete Freund's adjuvant in melanoma patients
Marit M. Melssen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Peptides as cancer vaccines
Marta Calvo Tardon et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
Self-Assembling Peptides and Their Application in the Treatment of Diseases
Sungeun Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
Hussein Sultan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Preparation of nanoliposomes linked to HER2/neu-derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer
Saeedeh Rastakhiz et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor
Leyuan Ma et al.
SCIENCE (2019)
Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy
Hyunjoon Kim et al.
BIOMATERIALS (2018)
Immunogenicity and antitumor activity of the superlytic lambda F7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice
Nastaran Barati et al.
CANCER LETTERS (2018)
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Muhammad Kashif Riaz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses
Erkko Ylosmaki et al.
MOLECULAR THERAPY (2018)
A facile approach to enhance antigen response for personalized cancer vaccination
Aileen Weiwei Li et al.
NATURE MATERIALS (2018)
The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide
Chunhui Lai et al.
THERANOSTICS (2018)
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice
Gabriele Galliverti et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu et al.
ONCOIMMUNOLOGY (2018)
A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model
Sangkyu Park et al.
ONCOTARGETS AND THERAPY (2018)
PLGA-Based Nanoparticles in Cancer Treatment
Sima Rezvantalab et al.
FRONTIERS IN PHARMACOLOGY (2018)
Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8+ T Cell Responses
Sue D. Xiang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
Gijs G. Zom et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
Peter G. Maslak et al.
BLOOD ADVANCES (2018)
Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
S. Rafiq et al.
LEUKEMIA (2017)
Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
Jie Gao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Addressing current challenges in cancer immunotherapy with mathematical and computational modelling
Anna Konstorum et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2017)
Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects
Naoya Miura et al.
MOLECULAR THERAPY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Anti-tumor activity of an immunotoxin (TGFa-PE38) delivered by attenuated Salmonella typhimurium
Daejin Lim et al.
ONCOTARGET (2017)
Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines
Eleni Maria Varypataki et al.
CANCER IMMUNOLOGY RESEARCH (2017)
The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
Terhi Karpanen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer
Braeden Donaldson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model
Atefeh Razazan et al.
PLOS ONE (2017)
A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9
Lukai Zhai et al.
ANTIVIRAL RESEARCH (2017)
Preclinical and clinical development of neoantigen vaccines
L. Li et al.
ANNALS OF ONCOLOGY (2017)
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases
Mark B. Faries et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
Songchuan Guo et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2017)
Supramolecular Assembly of Peptide Amphiphiles
Mark P. Hendricks et al.
ACCOUNTS OF CHEMICAL RESEARCH (2017)
Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model
Sahar Tahaghoghi-Hajghorbani et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
When self-assembly meets topology: an enhanced micelle stability
Xiaopeng Dong et al.
CHEMICAL COMMUNICATIONS (2017)
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
Kalijn F. Bol et al.
ONCOIMMUNOLOGY (2016)
Switching the Immunogenicity of Peptide Assemblies Using Surface Properties
Yi Wen et al.
ACS NANO (2016)
Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity
Laura Northrup et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Gardasil-9: A global survey of projected efficacy
Lukai Zhai et al.
ANTIVIRAL RESEARCH (2016)
The Emerging Role of B Cells in Tumor Immunity
Peiling Tsou et al.
CANCER RESEARCH (2016)
Low dose cyclophosphamide: Mechanisms of T cell modulation
Mutsa Tatenda Madondo et al.
CANCER TREATMENT REVIEWS (2016)
Improvement of anti-tumor immunity of fibroblast activation protein α based vaccines by combination with cyclophosphamide in a murine model of breast cancer
Qiu Xia et al.
CELLULAR IMMUNOLOGY (2016)
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
Mariette I. E. van Poelgeest et al.
CLINICAL CANCER RESEARCH (2016)
Biomaterials for enhancing anti-cancer immunity
Sandeep T. Koshy et al.
CURRENT OPINION IN BIOTECHNOLOGY (2016)
Current status and future prospects of peptide-based cancer vaccines
Satoshi Wada et al.
IMMUNOTHERAPY (2016)
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists
Salvatore Di Maro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
Tammy Oth et al.
MEDIATORS OF INFLAMMATION (2016)
Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery
Neda Habibi et al.
NANO TODAY (2016)
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
Gijs G. Zom et al.
ONCOTARGET (2016)
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
Elizabeth A. Mittendorf et al.
ONCOTARGET (2016)
Adjuvants for peptide-based cancer vaccines
Hiep Khong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
Christophe Macri et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Multivalent Antigens for Promoting B and T Cell Activation
Nitasha R. Bennett et al.
ACS CHEMICAL BIOLOGY (2015)
Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination
Gaute Lund Hansen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Supramolecular peptide vaccines: tuning adaptive immunity
Yi Wen et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Peptide therapeutics: current status and future directions
Keld Fosgerau et al.
DRUG DISCOVERY TODAY (2015)
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
Nikolai Petrovsky
DRUG SAFETY (2015)
Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses
Qin Zeng et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation
Sima Rahimian et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Functional characterization of biodegradable nanoparticles as antigen delivery system
A. Petrizzo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation
Teresa Lozano et al.
JOURNAL OF IMMUNOLOGY (2015)
Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs
Tammy Oth et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
Evan J. Lipson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry
Etienne Caron et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms
Ying-Chyi Song et al.
SCIENTIFIC REPORTS (2015)
The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm
Tirth Raj Ghimire
SPRINGERPLUS (2015)
Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination
Xue-Jun Zhu et al.
PLOS ONE (2015)
A Nanoparticle Based Sp17 Peptide Vaccine Exposes New Immuno-Dominant and Species Cross-reactive B Cell Epitopes
Sue D. Xiang et al.
VACCINES (2015)
PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines
Julien Fourcade et al.
CANCER RESEARCH (2014)
TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
Hongliang Fang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2014)
Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: A systematic review and meta-analysis
Ran Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2
Marian M. J. H. P. Willems et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
Hong Qin et al.
NATURE MEDICINE (2014)
Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand-Peptide Conjugates
Gijs G. Zom et al.
CANCER IMMUNOLOGY RESEARCH (2014)
HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells
Megan Jo Miller et al.
ONCOIMMUNOLOGY (2014)
Dendritic cell-targeted vaccines - hope or hype?
Wolfgang Kastenmueller et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Maryelise Cieslewicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Trial Watch Peptide vaccines in cancer therapy
Fernando Aranda et al.
ONCOIMMUNOLOGY (2013)
Modulating Adaptive Immune Responses to Peptide Self-Assemblies
Jai S. Rudra et al.
ACS NANO (2012)
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
Osama E. Rahma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Anti-tumor activity of immunomodulatory peptide alloferon-1 in mouse tumor transplantation model
Sergey Chernysh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Expression of GA733-Fc Fusion Protein as a Vaccine Candidate for Colorectal Cancer in Transgenic Plants
Zhe Lu et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
Else-Marit Inderberg-Suso et al.
ONCOIMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
Mary L. Disis
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
Veronique Corbiere et al.
CANCER RESEARCH (2011)
Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles
Yoshio Fujita et al.
CHEMISTRY CENTRAL JOURNAL (2011)
Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma
Amod A. Samaik et al.
CLINICAL CANCER RESEARCH (2011)
Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination
Wolfgang Kratky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model
Yifan Ma et al.
IMMUNOLOGY (2010)
A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice
Noelia Casares et al.
JOURNAL OF IMMUNOLOGY (2010)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The TLR3 agonist poly(I:C) targets CD8+T cells and augments their antigen-specific responses upon their adoptive transfer into naive recipient mice
Mohamed L. Salem et al.
VACCINE (2009)
Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis
Hai-yan Hong et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer
Elia Neninger Vinageras et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-β1
Lucia Gil-Guerrero et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
'Yin-Yang' functions of transforming growth factor-β and T regulatory cells in immune regulation
Yisong Y. Wan et al.
IMMUNOLOGICAL REVIEWS (2007)
Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms
Menaka Rajapakse et al.
BMC BIOINFORMATICS (2007)
Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells
Kaushal Rege et al.
CANCER RESEARCH (2007)
POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties
Chun-Wei Tung et al.
BIOINFORMATICS (2007)
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
Brian J. Czerniecki et al.
CANCER RESEARCH (2007)
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
Jan Wierecky et al.
CANCER RESEARCH (2006)
Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response
WWA Schamel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
MAGE-Al-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma
KA Chianese-Bullock et al.
JOURNAL OF IMMUNOLOGY (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu
J Jasinska et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Tandem mass tags:: A novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS
A Thompson et al.
ANALYTICAL CHEMISTRY (2003)
Determinant spreading and tumor responses after peptide-based cancer immunotherapy
A Ribas et al.
TRENDS IN IMMUNOLOGY (2003)
Antiviral and antitumor peptides from insects
S Chernysh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
ML Disis et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Beyond molecules: Self-assembly of mesoscopic and macroscopic components
GM Whitesides et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4
SK Basak et al.
BLOOD (2002)
Epitope spreading in immunemediated diseases: Implications for immunotherapy
CL Vanderlugt et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes
Y Amakata et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise
MG Hanna et al.
VACCINE (2001)
In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity
B Ludewig et al.
VACCINE (2000)
Share Paper
